ASTRAZENECA PLC financial data

Symbol
AZN on NYSE, AZNCF on OTC
Location
Cambridge
Fiscal year end
31 December
Latest financial report
20-F - Q4 2025 - 24 Feb 2026

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense $3,548,000,000 USD 18%

Balance Sheet

Label TTM Value / Value Unit Change %
Goodwill $21,242,000,000 USD 1%
Assets $114,074,000,000 USD 9.6%
Liabilities $65,355,000,000 USD 3.5%